Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting

Clinical trial NCT00642499 · COMPLETED

Trial details

NCT number: NCT00642499
Sponsor: Solvay Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Highly Active Antiretroviral Therapy (HAART)-Related Nausea and Vomiting HIV Infections

Start date: 2003-08-01
Primary completion: 2005-04-01
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.